was read the article
array:23 [ "pii" => "S0213005X13000128" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2013.01.007" "estado" => "S300" "fechaPublicacion" => "2014-01-01" "aid" => "893" "copyright" => "Elsevier España, S.L.. All rights reserved" "copyrightAnyo" => "2012" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2014;32:18-22" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2670 "formatos" => array:3 [ "EPUB" => 15 "HTML" => 1876 "PDF" => 779 ] ] "itemSiguiente" => array:18 [ "pii" => "S0213005X13000116" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2013.01.006" "estado" => "S300" "fechaPublicacion" => "2014-01-01" "aid" => "892" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2014;32:23-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 6910 "formatos" => array:3 [ "EPUB" => 16 "HTML" => 4115 "PDF" => 2779 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original</span>" "titulo" => "Características clínicas y pronóstico de la neumonía adquirida en la comunidad causada por <span class="elsevierStyleItalic">Staphylococcus aureus</span> resistente a la meticilina" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "23" "paginaFinal" => "27" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical features and outcome of community-acquired methicillin-resistant <span class="elsevierStyleItalic">Staphylococcus aureus</span> pneumonia" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1213 "Ancho" => 1584 "Tamanyo" => 152753 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Neumonía necrotizante por SARM de uno de los pacientes de la cohorte.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mora Obed, Carolina García-Vidal, Pedro Pessacq, Analia Mykietiuk, Diego Viasus, Laura Cazzola, M. Angeles Domínguez, Anibal Calmaggi, Jordi Carratalà" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Mora" "apellidos" => "Obed" ] 1 => array:2 [ "nombre" => "Carolina" "apellidos" => "García-Vidal" ] 2 => array:2 [ "nombre" => "Pedro" "apellidos" => "Pessacq" ] 3 => array:2 [ "nombre" => "Analia" "apellidos" => "Mykietiuk" ] 4 => array:2 [ "nombre" => "Diego" "apellidos" => "Viasus" ] 5 => array:2 [ "nombre" => "Laura" "apellidos" => "Cazzola" ] 6 => array:2 [ "nombre" => "M. Angeles" "apellidos" => "Domínguez" ] 7 => array:2 [ "nombre" => "Anibal" "apellidos" => "Calmaggi" ] 8 => array:2 [ "nombre" => "Jordi" "apellidos" => "Carratalà" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X13000116?idApp=UINPBA00004N" "url" => "/0213005X/0000003200000001/v1_201401150043/S0213005X13000116/v1_201401150043/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0213005X13000141" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2013.01.009" "estado" => "S300" "fechaPublicacion" => "2014-01-01" "aid" => "895" "copyright" => "Elsevier España, S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2014;32:11-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3041 "formatos" => array:3 [ "EPUB" => 12 "HTML" => 2253 "PDF" => 776 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "The use of MALDI-TOF ICMS as an alternative tool for <span class="elsevierStyleItalic">Trichophyton rubrum</span> identification and typing" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "11" "paginaFinal" => "17" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El uso de MALDI-TOF ICMS como una herramienta alternativa para la identificación y tipificación de <span class="elsevierStyleItalic">Trichophyton rubrum</span>" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2371 "Ancho" => 2167 "Tamanyo" => 287332 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Dendrogram resulting from single-linkage cluster analysis mass spectra of <span class="elsevierStyleItalic">T. rubrum</span> strains and out-group strains <span class="elsevierStyleItalic">T. interdigitale</span> (MUM 10.136 and MUM 12.07) and reference strain <span class="elsevierStyleItalic">T. mentagrophytes</span> (ATCC MYA-4439) obtained by MALDI-TOF ICMS analysis. Distances were measured as percentage of mass similarity.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Leonel Pereira, Nicolina Dias, Cledir Santos, Nelson Lima" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Leonel" "apellidos" => "Pereira" ] 1 => array:2 [ "nombre" => "Nicolina" "apellidos" => "Dias" ] 2 => array:2 [ "nombre" => "Cledir" "apellidos" => "Santos" ] 3 => array:2 [ "nombre" => "Nelson" "apellidos" => "Lima" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X13000141?idApp=UINPBA00004N" "url" => "/0213005X/0000003200000001/v1_201401150043/S0213005X13000141/v1_201401150043/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Long-term follow-up of jaw osteomyelitis associated with bisphosphonate use in a tertiary-care center" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "18" "paginaFinal" => "22" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Carlos Pigrau-Serrallach, Evelyn Cabral-Galeano, Benito Almirante-Gragera, Roger Sordé-Masip, Dolors Rodriguez-Pardo, Nuria Fernandez-Hidalgo, Nieves Larrosa-Escartín, Socorro Bescos-Atín, Albert Pahissa-Berga" "autores" => array:9 [ 0 => array:3 [ "nombre" => "Carlos" "apellidos" => "Pigrau-Serrallach" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 1 => array:4 [ "nombre" => "Evelyn" "apellidos" => "Cabral-Galeano" "email" => array:2 [ 0 => "evelyn.cabral@vhir.org" 1 => "evelyn_cabral@hotmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 2 => array:3 [ "nombre" => "Benito" "apellidos" => "Almirante-Gragera" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 3 => array:3 [ "nombre" => "Roger" "apellidos" => "Sordé-Masip" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Dolors" "apellidos" => "Rodriguez-Pardo" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 5 => array:3 [ "nombre" => "Nuria" "apellidos" => "Fernandez-Hidalgo" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 6 => array:3 [ "nombre" => "Nieves" "apellidos" => "Larrosa-Escartín" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 7 => array:3 [ "nombre" => "Socorro" "apellidos" => "Bescos-Atín" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 8 => array:3 [ "nombre" => "Albert" "apellidos" => "Pahissa-Berga" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Microbiology Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Maxillofacial Surgery Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "REIPI (Spanish Network for Research in Infectious Disease), Spain" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Osteomielitis maxilar asociada al tratamiento con bifosfonatos en un hospital terciario: seguimiento a largo plazo" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Bisphosphonate-associated osteomyelitis of the jaw (BJOM) is a relatively common side effect of bisphosphonate therapy.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–7</span></a> BJOM is the result of mandibular bone infection secondary to bone exposure due to bisphosphonate-associated osteonecrosis.</p><p id="par0010" class="elsevierStylePara elsevierViewall">More than 90% of the cases are associated with intravenous therapy, with an estimated risk in the range of 2% to 10%.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–7</span></a> Less commonly, BJOM is associated with prolonged oral bisphosphonate therapy, with a current risk of 0.001–0.1%.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> Bone infection is a common complication in advanced stages of this condition. Although several studies have been published on this subject, they have mainly focused on the initial clinical features and risk factors of the disease. Little information is available on the microbiology and antimicrobial susceptibility of the isolated microorganisms or the findings at long-term follow-up.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,6,7,9,10</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Our clinical experience suggests that patients with BJOM are difficult to treat. Furthermore, the bone can be infected with microorganisms resistant to conventional antibiotics used for the treatment of maxillofacial infections. The purpose of this study was to review our clinical experience in patients with BJOM, focusing on the etiology, antimicrobial resistance features and long-term outcome of this condition.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Patients and methods</span><p id="par0020" class="elsevierStylePara elsevierViewall">We retrospectively reviewed the medical records of all consecutive adult patients with jaw osteomyelitis (JO) diagnosed at Vall d’Hebron Hospital from January 1995 to December 2008, focusing on those cases associated with bisphosphonate use. Our hospital is a 1250-bed tertiary referral center for complicated maxillofacial surgical patients. Patients were identified from the Infectious Diseases Department's JO registry. All patients diagnosed with BJOM were evaluated and followed-up by the same Infectious Disease Department staff member.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The diagnosis of bisphosphonate jaw osteonecrosis was established according to the report of a task force of the American Society for Bone and Mineral Research,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> which includes current or previous treatment with bisphosphonate, exposed bone in the maxillofacial region persisting for >8 weeks, and no history of radiation therapy to the jaws.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The diagnosis of JO was established according to published criteria<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a>: (a) presence of a compatible clinical picture with purulence, fistula, or recurrent abscess; (b) consistent imaging findings on plain radiographs, and/or computed tomography, and/or increased uptake on triphasic technetium bone scan; and (c) a histological picture consistent with osteomyelitis, and/or a positive leukocyte bone scan. Microorganisms were isolated in samples of excised bone obtained by surgery, percutaneous bone biopsy samples, or pus aspiration from adjacent tissues. Only <span class="elsevierStyleItalic">Streptococcus viridans</span> isolated of bone and pus aspiration samples were considered evaluable. Samples were cultured as previously described.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> Streptococci intermediately resistant to penicillin (0.2–2<span class="elsevierStyleHsp" style=""></span>mg/L) were considered resistant. Appropriate antibiotics were given according to culture findings, antibiotic allergy history, and susceptibility studies.</p><p id="par0035" class="elsevierStylePara elsevierViewall">We collected demographic data; underlying medical illnesses, particularly osteoporosis and neoplastic disease; clinical features; type and duration of bisphosphonate therapy and previous antibiotic therapy used for BJOM; radiological and histological findings; bacteriologic cultures; treatment and outcome. To assess the effectiveness of antibiotic and surgical therapy, only patients followed-up for at least one year to detect relapses after completion of antibiotic therapy were considered. Clinical failure was established on persistent clinical signs of infection (purulence) or relapse. Relapse was defined as recurrence of clinical signs of osteomyelitis (purulence, new fistula or abscess) and/or recurrence of pain, plus a new positive leukocyte bone scan or new bone sequestrum on imaging study, plus isolation of a microorganism in bone or pus aspiration samples.</p><p id="par0040" class="elsevierStylePara elsevierViewall">All cases were classified according to the AAOMS staging system for BJOM,<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> as stage II (evidence of infection) or stage III (evidence of infection and at least one of the following criteria: pathologic fracture, extra-oral fistula, or osteolysis extending to the inferior border). None of the cases were classified in stage I, since this stage applies to patients with bone exposure without signs of infection.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Quantitative variables are reported as the median and interquartile range<span class="elsevierStyleInf">25–75</span> (IQR). The chi-square test (or Fisher's exact test when appropriate) was used to compare the distribution of categorical variables. Differences were considered significant at a <span class="elsevierStyleItalic">P</span>-value of <0.05. Statistical analyses were performed with Microsoft SPSS-PC+, version 15.0 (SPSS, Chicago, IL, USA).</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Results</span><p id="par0050" class="elsevierStylePara elsevierViewall">During the study period, 30 of 132 (22.7%) consecutive cases of JO were found to associate with bisphosphonate use. Twenty-five (83.3%) were women, and median age was 69 years (IQR 57.5–75.0 years). The percentage of BJOM cases increased from 8.7% (4/46) in the 1995–2005 period,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> to 30.2% (26/86) during 2005–2008. Twenty-eight patients (93.3%) had mandibular involvement (one had bilateral lesions) and two had maxillary involvement. There was a history of diabetes mellitus in 3, smoking in 3 and alcoholism (>100<span class="elsevierStyleHsp" style=""></span>g/day) in one. The 30 patients suffered a total of 44 episodes of JO.</p><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Bisphosphonate therapy</span><p id="par0055" class="elsevierStylePara elsevierViewall">Bisphosphonates were administered intravenously for metastatic neoplastic disease in 19 (63.3%) patients (breast cancer in 13, multiple myeloma in 3, prostate carcinoma in 2, and renal carcinoma in 1); zoledronate was used in 18 and pamidronate in 1 patient. In the remaining 11 patients, bisphosphonates were administered orally for osteoporosis (alendronate: 8 and risedronate: 3). The median duration of intravenous bisphosphonate therapy was 2.5 years (IQR 1.5–4 years), whereas the median of oral exposure was 4.5 years (IQR 4.5–5.0 years). One patient who additionally received an antiangiogenic agent (sorafenib) for underlying neoplastic disease developed BJOM after only 6 months of intravenous bisphosphonate therapy.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Clinical features</span><p id="par0060" class="elsevierStylePara elsevierViewall">Clinical features of JO were present for a median of 4.5 months (IQR 2–10.5 months). The most common symptoms were pain (100%) and intraoral exposed necrotic bone was observed in 30 cases, followed by external swelling in 22, sinus formation in 6 and chin paresthesia in 6. In 12 patients (40%), the symptoms appeared after a recent (<1 month) tooth extraction, with non-healing of the extraction site.</p><p id="par0065" class="elsevierStylePara elsevierViewall">All patients had prior exposure to one or more cycles of antibiotics, for short periods (less than 3 weeks), for relapsing maxillofacial dental infection; twenty-one had received a beta-lactam, 14 clindamycin, and 5 other antibiotics (levofloxacin, azithromycin) before the microbiological diagnosis of BJOM was established.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Radiological findings</span><p id="par0070" class="elsevierStylePara elsevierViewall">Maxillary computed tomography was performed in all cases and findings were consistent with osteomyelitis in all patients. Bone sequestrum formation was observed in 25 (83%) patients, and 3 had pathologic fractures. According to the AAOMS, 18 (60%) patients were classified as having stage II and 12 patients as having stage III BJOM. Leukocyte bone scanning showed increased uptake in all 18 patients in whom it was performed.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Microbiology</span><p id="par0075" class="elsevierStylePara elsevierViewall">Among the 30 cases studied, the infection was monomicrobial in 14 (47%) patients and polymicrobial in 13 (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Viridans group streptococci (VGS) were the most commonly isolated agents (83.3%). On bone histological study, Gram-positive bacilli suggestive of <span class="elsevierStyleItalic">Actinomyces</span> spp. were observed in 10/30 cases. Overall, initial episode plus further biopsies of clinical failures, in 16/41 (39%) episodes, the histological findings were suggestive of <span class="elsevierStyleItalic">Actinomyces</span> spp. infection (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). All three cases of culture negative BJOM had clinical and radiological signs compatible with JO and a histological picture suggestive of osteomyelitis. All 3 patients had received previous antibiotic therapy, which may have negativized the culture results.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">Antimicrobial susceptibilities of VGS are shown in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>. Only 35% of the isolates were susceptible to erythromycin studied and 52.9% to clindamycin. All nonsusceptible clindamycin streptococcal strains were nonsusceptible to erythromycin, which suggests an erm-encoding MLS resistance. All patients infected with nonsusceptible VGS strains except one had been previously exposed to the same antibiotic.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Medical treatment</span><p id="par0085" class="elsevierStylePara elsevierViewall">Once BJOM was diagnosed, bisphosphonates were stopped in all patients.</p><p id="par0090" class="elsevierStylePara elsevierViewall">All patients had been previously treated conservatively with antibiotic therapy and clorhexidine rinses.</p><p id="par0095" class="elsevierStylePara elsevierViewall">Definitive antibiotic therapy was adjusted to surgical culture results. It was administered orally in all patients except one, who additionally had an extended-spectrum beta-lactamase <span class="elsevierStyleItalic">Escherichia coli</span> infection, and was treated with 8 weeks intravenous ertapenem therapy. The initial antibiotic therapy administered in the 30 cases is shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.</p><p id="par0100" class="elsevierStylePara elsevierViewall">Patients with <span class="elsevierStyleItalic">Actinomyces</span> spp. infection were treated orally for a median of 6 months (IQR 3–6 months) with a beta-lactam antibiotic (amoxicillin or amoxicillin–clavulanate).</p><p id="par0105" class="elsevierStylePara elsevierViewall">The length of antibiotic therapy ranged from 2 to 13 months, median 6 months. The duration of antibiotic therapy was similar for stage II and III BJOM episodes.</p><p id="par0110" class="elsevierStylePara elsevierViewall">Hyperbaric oxygen therapy was applied in one patient who presented a BJOM relapse, with unsuccessful results.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Surgical therapy</span><p id="par0115" class="elsevierStylePara elsevierViewall">All 30 patients underwent at least one surgical procedure. Surgery ranged from debridement to marginal resections. Sequestrectomy was performed initially in 19/25 (76%) patients with bone sequestra. Twelve patients (5 in which a sequestrum had not been removed initially, 2 in which a sequestrum developed during the follow-up and in 5 in which a new sequestrum was observed during the follow up) additionally required sequestrectomy; thus, sequestrectomy was performed in 27/30 (90%) patients and overall, in 31/44 (70.5%) episodes. Primary surgical closure of bone exposure was carried out in 4 cases (all treated during the last study year) and with no relapses, and secondary closure was performed in a second surgical procedure in 5 cases.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Follow-up</span><p id="par0120" class="elsevierStylePara elsevierViewall">Among the 30 patients studied, 3 died due to the underlying neoplastic disease before completion of antibiotic therapy, and 27 had a long-term follow-up, median 22 months (IQR 17–28). Clinical failure occurred in 13 (48.1%). Four had persistent infection and 9 experienced BJOM relapse (1 relapse in 8 patients and 2 relapses in 1), requiring further antibiotic therapy and surgery (mean, 2.24 surgical procedures). The median time to relapse was 4.5 months (IQR 2–9 months). Patients without relapse were followed-up for a median of 26 months (IQR 19.7–44.7 months) after stopping antibiotic therapy. Among the 13 clinical failures, the same microorganism (VGS cases had the same antibiotic susceptibility pattern) was isolated in the second culture in 8 (61.6%) patients, and 5 were considered reinfections. In 6/13 (46.2%) clinical failures, <span class="elsevierStyleItalic">Actinomyces</span> spp. was observed on the second bone histological study.</p><p id="par0125" class="elsevierStylePara elsevierViewall">Clinical failure (persistent infection or relapse) was more common in patients exposed to intravenous bisphosphonates (11/16, 68.8%) than in those with oral phosphonate therapy (2/11, 18.2%) (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.05). Clinical failure rates were 54.5% (6/11) in stage III disease and 43.8% (7/16) in stage II (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>NS). Of the 25 patients who initially had a bone sequestrum, clinical failure occurred in 3/6 cases (50%) in which bone sequestra were not removed and in 5/19 (26.3%) in which sequestra were removed (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>NS). Clinical failure was documented in 7/10 cases (70%) with <span class="elsevierStyleItalic">Actinomyces</span> spp. microorganisms on the first histological study versus 6/17 (35.3%) without these findings (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.08). Clinical failure had no relation with the duration of the antimicrobial therapy.</p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Discussion</span><p id="par0130" class="elsevierStylePara elsevierViewall">The results of our study show that bisphosphonate therapy is now a common cause of JO. In our earlier experience (1993–2005), 8% of JO cases were associated with this therapy,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> whereas our current data (2005–2008) show that one-third of cases are related to this treatment. Furthermore, this drug-related complication is difficult to cure: the failure rate is 48.1%, a percentage considerably higher then the 5% observed in our general series of JO.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">This drug-related side effect has been particularly associated with intravenous administration, with a risk as high as 10%.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1–7</span></a> Nowadays, use of oral nitrogen-containing bisphosphonates accounts for 5–10% of cases of BJOM. Higher periods of drug exposure are needed in oral therapy. In our study, the median time of oral exposure before the development of BJOM was 4.5 years, a value similar to previously reported data (4.4 years),<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> and the median time of intravenous exposure was 2.5 years.</p><p id="par0140" class="elsevierStylePara elsevierViewall">Although the potency, dose and length of bisphosphonate exposure are the most important risk factors for developing BJOM,<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2–6</span></a> it has been suggested that other factors, such as traumatism, poor dental hygiene, smoking, chemotherapeutic drugs, and corticosteroids, might have a role in the development of the disease.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,11</span></a></p><p id="par0145" class="elsevierStylePara elsevierViewall">In vitro and animal studies have shown that bisphosphonates also inhibit angiogenesis.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> In one patient of our series who was under treatment with an antiangiogenic agent, clinical symptoms of BJOM appeared after only 6 months of intravenous bisphosphonate exposure. A higher than usual incidence (18.3%) of jaw osteonecrosis has recently been reported in metastatic prostate cancer treated with bisphosphonates and docetaxel, prednisone and 2 antiangiogenic agents such bevacizumab and thalidomide, which suggests that antiangiogenic therapy may enhanced the effects of bisphosphonates on avascularization.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> In this situation, close follow-up may enable earlier detection of jaw osteonecrosis and facilitate a prompt intervention.</p><p id="par0150" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Viridans</span> group streptococci were the most commonly isolated microorganisms with a percentage 75.6% that was similar to the 83.3% of our previous global series of JO.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> The high incidence of clindamycin-resistant strains (half the cases) and the resistance to penicillin in some cases (15%), which we also observed in other types of JO,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> are likely related to previous therapy with these antibiotics. These findings argue against empirical antibiotic therapy and suggest that antimicrobial susceptibility tests are needed.</p><p id="par0155" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Actinomyces</span>-like organisms were observed on histological study in 33% (10/30) of the patients, a percentage quite higher that the 7.3% (3/46%) in our global series of JO<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a>; however, the microorganism could not be isolated on culture. These findings are consistent with recent observations of a nearly universal presence of this pathogen on histological study, with few cases of isolation on culture.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,9,16–20</span></a> Isolation of this pathogen is likely difficult, particularly in patients who have previously received antibiotic therapy.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> Given the low yield of culture, molecular procedures such as polymerase chain reaction (PCR) testing of decalcified bone specimens may prove to be a useful alternative for identification of <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> This can have therapeutic implications, since high doses of antimicrobials and a prolonged course (6 months or longer) are required to cure the disease.<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">16,18</span></a> The higher incidence of <span class="elsevierStyleItalic">Actinomyces</span> spp. found in cases of JO associated with bisphosphonate therapy could be due to a higher anaerobic environment secondary to the avascular jaw ostenecrosis caused by bisphosphonates which may predispose to the growth of this microorganism.</p><p id="par0160" class="elsevierStylePara elsevierViewall">Even though bisphosphonates were stopped once BJOM had been diagnosed, specific antibiotics were administered according to susceptibility testing, and aggressive surgery with sequestrectomy was performed in most cases, BJOM relapsed in half our patients, particularly those with advanced disease (stage III) and those in whom bone sequestra were not removed. Management of this disease is difficult. Some authors have advocated an aggressive surgical approach with extensive bone resection and sequestrectomy,<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3,13,21,22</span></a> whereas others have proposed a more conservative approach particularly for stages I and II.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3–6,9,23,24</span></a> With the currently available data, it is difficult to establish the ideal surgical approach. Although our results are not conclusive, our data showing clinical failure in 50% of patients without bone sequestrum removal versus 26% with removal, and data from a recent German multicenter study in 78 patients, reporting response in only 38% of the conservative group versus 86% in the radical bone resection group, favor a more aggressive attitude, at least in advanced stages of the disease. In a recent study the extent of radiographic appearance, surgical therapy vs conservative treatment, extensive surgical treatment and number of debridements were associated with lower recurrence rates.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> Because of our high failure rate, the surgical team has attempted to close the bone exposure in the most recently treated patients. Although, our experience in this line is limited, the long-term follow-up in four cases treated with this approach has indicated success. Attempts to close the exposed area or cover it with a soft vinyl splint may be useful to avoid super-infection,<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> which occurred in 38.5% of our clinical failures.</p><p id="par0165" class="elsevierStylePara elsevierViewall">The role of hyperbaric oxygen and ozone therapy for this condition, which in one small study seemed to show some benefit,<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a> should be established in prospective studies.</p><p id="par0170" class="elsevierStylePara elsevierViewall">Our study has some limitations. As in all retrospective studies, there is a potential for flaws because of bias and statistical imprecision. The lack of data on bisphosphonate use in our hospital and the fact that we do not have data on how many cases were referred from other centers hinders an analysis of the true incidence of this drug side effect. Some variables such as dental care and the administration of antineoplasic antiangiogenic agents were not systematically recorded; however, data on type and length of bisphosphonate therapy were collected in all cases by the same infectious disease staff members. Furthermore, <span class="elsevierStyleItalic">Actinomyces</span> spp. was not routinely investigated by prolonged incubation in microbiological cultures or by PCR analysis; hence the incidence of this microorganism may be underestimated.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conclusion</span><p id="par0175" class="elsevierStylePara elsevierViewall">In conclusion, bisphosphonate therapy is now a common cause of JO. Even with specific antimicrobial therapy and surgery, the disease is difficult to cure and relapses are common, especially in patients exposed to intravenous bisphosphonates, those with stage III disease, and cases involving actinomycosis. Further studies focusing on the degree o aggressiveness required in surgery and the role of <span class="elsevierStyleItalic">Actinomyces</span> spp. in this condition are needed.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflict of interest</span><p id="par0180" class="elsevierStylePara elsevierViewall">Authors have no conflict of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:2 [ "identificador" => "xres303536" "titulo" => array:5 [ 0 => "Abstract" 1 => "Objectives" 2 => "Methods" 3 => "Results" 4 => "Conclusions" ] ] 1 => array:2 [ "identificador" => "xpalclavsec286679" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres303537" "titulo" => array:5 [ 0 => "Resumen" 1 => "Objetivos" 2 => "Métodos" 3 => "Resultados" 4 => "Conclusiones" ] ] 3 => array:2 [ "identificador" => "xpalclavsec286678" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Patients and methods" ] 6 => array:3 [ "identificador" => "sec0015" "titulo" => "Results" "secciones" => array:7 [ 0 => array:2 [ "identificador" => "sec0020" "titulo" => "Bisphosphonate therapy" ] 1 => array:2 [ "identificador" => "sec0025" "titulo" => "Clinical features" ] 2 => array:2 [ "identificador" => "sec0030" "titulo" => "Radiological findings" ] 3 => array:2 [ "identificador" => "sec0035" "titulo" => "Microbiology" ] 4 => array:2 [ "identificador" => "sec0040" "titulo" => "Medical treatment" ] 5 => array:2 [ "identificador" => "sec0045" "titulo" => "Surgical therapy" ] 6 => array:2 [ "identificador" => "sec0050" "titulo" => "Follow-up" ] ] ] 7 => array:2 [ "identificador" => "sec0055" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0060" "titulo" => "Conclusion" ] 9 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflict of interest" ] 10 => array:2 [ "identificador" => "xack72411" "titulo" => "Acknowledgment" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2012-07-06" "fechaAceptado" => "2013-01-17" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec286679" "palabras" => array:5 [ 0 => "Jaw osteomyelitis" 1 => "Jaw osteonecrosis" 2 => "Bisphosphonates" 3 => "Bisphosphonate-related osteonecrosis" 4 => "Bisphosphonate-related jaw osteomyelitis" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec286678" "palabras" => array:5 [ 0 => "Osteomielitis maxilar" 1 => "Osteonecrosis maxilar" 2 => "Bifosfonatos" 3 => "Osteonecrosis relacionada con bifosfonatos" 4 => "Osteomielitis maxilar relacionada con bifosfonatos" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle">Objectives</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">This study reviews our experience in bisphosphonate-associated jaw osteomyelitis (BJOM), focusing on the incidence, etiology, treatment, and long-term outcome.</p> <span class="elsevierStyleSectionTitle">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Retrospective review of the clinical histories adult patients diagnosed with BJOM (1995–2008) in a tertiary hospital.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">BJOM was found in 30 of 132 (22.7%) consecutive patients with jaw osteomyelitis. The percentage of BJOM cases increased from 8.7% (4/46) in 1995–2005 to 30.2% (26/86) in 2005–2008. Symptoms appeared in a median of 2.5 years after intravenous use, and 4.5 years after oral exposure. Viridans group streptococci were isolated in 83.3% of cases. <span class="elsevierStyleItalic">Actinomyces</span> spp. was found in 16 (39.0%) of 41 bone histologies. All included patients received a median of 6 months of appropiate antibiotic therapy and a surgical procedure (debridament and/or sequestrectomy). Thirteen of 27 cases (48.1%) with long-term follow-up (median 22 months, IQR <span class="elsevierStyleInf">25–75</span> 17–28) failed. Clinical failure defined as, persistent infection or relapse, was more frequent in patients receiving intravenous than oral bisphosphonates (11/16 [68.8%] vs. 2/11 [18.2%]; P < .05) and in cases with Actinomyces spp. (7/10 [70.0%] vs6/17 [35.3%]; P = .08).</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Bisphosphonate therapy is now a frequent cause of JO. BJOM is difficult to cure and relapses are common, particularly in patients exposed to intravenous bisphosphonates.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span class="elsevierStyleSectionTitle">Objetivos</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Analizar la incidencia, la etiología, el tratamiento y la evolución clínica a largo plazo de la osteomielitis maxilar (OM) asociada al tratamiento con bifosfonatos (OMAB).</p> <span class="elsevierStyleSectionTitle">Métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Estudio retrospectivo de pacientes adultos con diagnóstico de OMAB (1995-2008) en un hospital universitario.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Fueron diagnosticadas 30<span class="elsevierStyleHsp" style=""></span>OMAB de un total de 132<span class="elsevierStyleHsp" style=""></span>OM. Desde el año 1995 al 2004 fueron diagnosticadas 4<span class="elsevierStyleHsp" style=""></span>OMAB de 46<span class="elsevierStyleHsp" style=""></span>OM (8,7%), y desde el año 2005 al 2008, 26 de 86 (30,2%). Los síntomas de osteomielitis aparecieron en una mediana de 2,5<span class="elsevierStyleHsp" style=""></span>años en los pacientes que recibieron el tratamiento con bifosfonatos por vía intravenosa y una mediana de 4,5<span class="elsevierStyleHsp" style=""></span>años en los pacientes que lo recibieron por vía oral. En el 83,3% se aislaron <span class="elsevierStyleItalic">Streptococcus</span> del grupo <span class="elsevierStyleItalic">viridans</span>. En 16 (39%) de 41<span class="elsevierStyleHsp" style=""></span>muestras enviadas para estudio histológico se constató la presencia de <span class="elsevierStyleItalic">Actinomyces</span> spp. Todos los pacientes fueron sometidos a desbridamiento quirúrgico y/o secuestrectomía y recibieron una mediana de 6<span class="elsevierStyleHsp" style=""></span>meses de tratamiento antibiótico. Trece de los 27<span class="elsevierStyleHsp" style=""></span>casos (48,1%) con seguimiento a largo plazo (mediana 22<span class="elsevierStyleHsp" style=""></span>meses, IQR<span class="elsevierStyleInf">25-75</span> 17-28) presentaron fracaso terapéutico. Estos fueron más frecuentes en pacientes que recibieron bifosfonatos por vía intravenosa en comparación con los que los recibieron por vía oral (11/16 [68,8%] vs 2/11 [18,2%], p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,05) y en los casos con <span class="elsevierStyleItalic">Actinomyces</span> spp. (7/10 [70,0%] vs 6/17 [35,3%], p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,08).</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Actualmente el tratamiento con bifosfonatos es causa frecuente de OM. Las recidivas son frecuentes en las OMAB, especialmente en pacientes expuestos a los bifosfonatos por vía intravenosa.</p>" ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:3 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">BJOM: bisphosphonate-related jaw osteomyelitis, AB: antibiotic, VGS: Viridans group streptococci, ESBL: extended-spectrum beta lactamases.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">N</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Initial cultures \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Initial AB therapy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Outcome \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Follow-up cultures</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Levofloxacin<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>clindamycin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Enterococcus, <span class="elsevierStyleItalic">Klebsiella pneumoniae</span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Negative culture</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cefixime \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Persistence \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>, <span class="elsevierStyleItalic">Bacteroides</span> spp. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Actinomyces</span> spp.</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Levofloxacin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Exitus<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cotrimoxazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">VGS</span>, <span class="elsevierStyleItalic">Klebsiella oxytoca</span>, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>, C<span class="elsevierStyleItalic">orynebacterium</span> spp. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cefixime \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Prevotella</span> spp.</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Exitus<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">VGS</span>, <span class="elsevierStyleItalic">Corynebacterium</span> spp. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Levofloxacin<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>clindamycin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">13 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cefixime \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">2</span>° <span class="elsevierStyleItalic">Relapse</span>VGS<span class="elsevierStyleItalic">Actinomyces</span> spp. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Levofloxacin +Rifampin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cotrimoxazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">VGS.</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">17 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Peptostreptococcus</span> spp. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">18 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Enterococcus</span> spp. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Persistence \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">19 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">VGS</span>, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Persistence \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">VGS</span>, <span class="elsevierStyleItalic">E. coli</span> ESBL</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Relapse \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Candida</span> spp.</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">22 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">23 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Staphylococcus aureus</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cotrimoxazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS, <span class="elsevierStyleItalic">Actinomyces</span> spp.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Persistence \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">26 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clindamycin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">27 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Negative culture \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Negative culture \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Exitus<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Rothia dentocariosa</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Levofloxacin<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>rifampin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amoxicillin/clavulanate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"></td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab448159.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara">Only proven by histological findings.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara">Death related to the underlying neoplastic disease.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Etiological agents, initial antibiotic therapy, and outcome from 30 patients with BJOM.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleSup">a</span>Streptococci intermediately resistant to penicillin (0.2–2<span class="elsevierStyleHsp" style=""></span>mg/L) were considered resistant.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Antibiotic \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">N</span> studied \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">N</span> susceptible (%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Penicillin<span class="elsevierStyleSup">a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 (85.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Clindamycin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">18 (52.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Erythromycin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 (35.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Rifampin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">34 (100%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Trimethoprim-sulfamethoxazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28 (82.4%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab448158.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Antimicrobial susceptibilities of <span class="elsevierStyleItalic">viridans</span> group streptococci.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:26 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.A. Migliorati" 1 => "M.M. Schubert" 2 => "D.E. Peterson" 3 => "L.M. Seneda" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.21130" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "2005" "volumen" => "104" "paginaInicial" => "83" "paginaFinal" => "93" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15929121" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.O. Hoff" 1 => "B.B. Toth" 2 => "K. Altundag" 3 => "M.M. Johnson" 4 => "C.L. Warneke" 5 => "M. Hu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.080205" "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2008" "volumen" => "23" "paginaInicial" => "826" "paginaFinal" => "836" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18558816" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteonecrosis of the jaw and the role of bisphosphonates: a critical review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.L. Silverman" 1 => "R. Landesberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2009.01.006" "Revista" => array:7 [ "tituloSerie" => "Am J Med" "fecha" => "2009" "volumen" => "122" "numero" => "Suppl." "paginaInicial" => "S33" "paginaFinal" => "S45" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19410675" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.L. Ruggiero" 1 => "B. Mehrotra" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1146/annurev.med.60.063007.134350" "Revista" => array:6 [ "tituloSerie" => "Annu Rev Med" "fecha" => "2009" "volumen" => "60" "paginaInicial" => "85" "paginaFinal" => "96" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18928335" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.B. Woo" 1 => "J.W. Hellstein" 2 => "J.R. Kalmar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2006" "volumen" => "144" "paginaInicial" => "753" "paginaFinal" => "761" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16702591" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.E. Marx" 1 => "Y. Sawatari" 2 => "M. Fortin" 3 => "V. Broumand" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.joms.2005.07.010" "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2005" "volumen" => "63" "paginaInicial" => "1567" "paginaFinal" => "1575" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16243172" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Badros" 1 => "D. Weikel" 2 => "A. Salama" 3 => "O. Goloubeva" 4 => "A. Schneider" 5 => "A. Rapoport" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/JCO.2005.04.2465" "Revista" => array:6 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2006" "volumen" => "24" "paginaInicial" => "945" "paginaFinal" => "952" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16484704" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.C. Lo" 1 => "F.S. O’Ryan" 2 => "N.P. Gordon" 3 => "J. Yang" 4 => "R.L. Hui" 5 => "D. Martin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.joms.2009.03.050" "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2010" "volumen" => "68" "paginaInicial" => "243" "paginaFinal" => "253" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19772941" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.L. Ruggiero" 1 => "B. Mehrotra" 2 => "T.J. Rosenberg" 3 => "S.L. Engroff" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2004" "volumen" => "62" "paginaInicial" => "527" "paginaFinal" => "534" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15122554" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Pozzi" 1 => "R. Marcheselli" 2 => "S. Sacchi" 3 => "L. Baldini" 4 => "F. Angrilli" 5 => "E. Pennese" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/10428190600977690" "Revista" => array:6 [ "tituloSerie" => "Leuk Lymphoma" "fecha" => "2007" "volumen" => "48" "paginaInicial" => "56" "paginaFinal" => "64" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17325848" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Khosla" 1 => "D. Burr" 2 => "J. Cauley" 3 => "D.W. Dempster" 4 => "P.R. Ebeling" 5 => "D. Felsenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1359/jbmr.0707onj" "Revista" => array:6 [ "tituloSerie" => "J Bone Miner Res" "fecha" => "2007" "volumen" => "22" "paginaInicial" => "1479" "paginaFinal" => "1491" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17663640" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Pigrau" 1 => "B. Almirante" 2 => "D. Rodriguez" 3 => "N. Larrosa" 4 => "S. Bescos" 5 => "G. Raspall" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10096-008-0626-z" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Microbiol Infect Dis" "fecha" => "2009" "volumen" => "28" "paginaInicial" => "317" "paginaFinal" => "323" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18797941" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "American Academy of Oral and Maxillofacial Surgeons. Position paper on bisphosphonates-related osteonecrosis of the Jaws. Available at: <a class="elsevierStyleInterRef" href="http://www.%20aaoms.org/docs/position_papers/osteonecrosis.pdf">http://www. Aaoms.org/docs/position_papers/osteonecrosis.pdf</a> (accessed 11.12.06)." ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Wood" 1 => "K. Bonjean" 2 => "S. Ruetz" 3 => "A. Bellahcene" 4 => "L. Devy" 5 => "J.M. Foidart" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1124/jpet.102.035295" "Revista" => array:6 [ "tituloSerie" => "J Pharmacol Exp Ther" "fecha" => "2002" "volumen" => "302" "paginaInicial" => "1055" "paginaFinal" => "1061" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12183663" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.B. Aragon-Ching" 1 => "Y.M. Ning" 2 => "C.C. Chen" 3 => "L. Latham" 4 => "J.P. Guadagnini" 5 => "J.L. Gulley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/07357900802208608" "Revista" => array:6 [ "tituloSerie" => "Cancer Invest" "fecha" => "2009" "volumen" => "27" "paginaInicial" => "221" "paginaFinal" => "226" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19235596" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Agents of actinomycosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "T. Russo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Principles and practice of infectious diseases" "paginaInicial" => "3209" "paginaFinal" => "3219" "edicion" => "7th ed." "serieFecha" => "2010" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Actinomycosis of the jaws—histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Hansen" 1 => "M. Kunkel" 2 => "E. Springer" 3 => "C. Walter" 4 => "A. Weber" 5 => "E. Siegel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00428-007-0516-2" "Revista" => array:6 [ "tituloSerie" => "Virchows Arch" "fecha" => "2007" "volumen" => "451" "paginaInicial" => "1009" "paginaFinal" => "1017" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17952459" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "N.H. Naik" 1 => "T.A. Russo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/648075" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2009" "volumen" => "49" "paginaInicial" => "1729" "paginaFinal" => "1732" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19886792" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of jaw secondary to bisphosphonate therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P.P. Sedghizadeh" 1 => "S.K. Kumar" 2 => "A. Gorur" 3 => "C. Schaudinn" 4 => "C.F. Shuler" 5 => "J.W. Costerton" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Ala Dent Assoc" "fecha" => "2009" "volumen" => "140" "paginaInicial" => "1259" "paginaFinal" => "1265" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.A. Arranz" 1 => "E. Flores" 2 => "S. Ngo" 3 => "V. lopez" 4 => "J.L. Dominguez" 5 => "A. restoy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Med Clin" "fecha" => "2012" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "“Bis-phossy jaws”—high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.H. Abu-Id" 1 => "P.H. Warnke" 2 => "J. Gottschalk" 3 => "I. Springer" 4 => "J. Wiltfang" 5 => "Y. Acil" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcms.2007.06.008" "Revista" => array:6 [ "tituloSerie" => "J Craniomaxillofac Surg" "fecha" => "2008" "volumen" => "36" "paginaInicial" => "95" "paginaFinal" => "103" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18234504" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "O. Nicolatou-Galitis" 1 => "E. Papadopoulou" 2 => "T. Sarri" 3 => "P. Boziari" 4 => "A. Karayianni" 5 => "M.C. Kyrtsonis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.tripleo.2011.02.037" "Revista" => array:6 [ "tituloSerie" => "Oral Surg Oral Med Oral Pathol Oral Radiol Endod" "fecha" => "2011" "volumen" => "112" "paginaInicial" => "195" "paginaFinal" => "202" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21622014" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T.S. Lazarovici" 1 => "R. Yahalom" 2 => "S. Taicher" 3 => "S. Elad" 4 => "I. Hardan" 5 => "N. Yarom" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.joms.2008.11.015" "Revista" => array:6 [ "tituloSerie" => "J Oral Maxillofac Surg" "fecha" => "2009" "volumen" => "67" "paginaInicial" => "850" "paginaFinal" => "855" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19304045" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C.A. Migliorati" 1 => "J. Casiglia" 2 => "J. Epstein" 3 => "P.L. Jacobsen" 4 => "M.A. Siegel" 5 => "S.B. Woo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Am Dent Assoc" "fecha" => "2005" "volumen" => "136" "paginaInicial" => "1658" "paginaFinal" => "1668" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16383047" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaw" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Mücke" 1 => "J. Kochschinski" 2 => "H. Deppe" 3 => "S. Wagenpfeil" 4 => "C. Pautke" 5 => "D.A. Mitchell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00432-010-0953-1" "Revista" => array:6 [ "tituloSerie" => "J Cancer Res Clin Oncol" "fecha" => "2001" "volumen" => "137" "paginaInicial" => "907" "paginaFinal" => "913" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20927569" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.T. Petrucci" 1 => "C. Gallucci" 2 => "A. Agrillo" 3 => "M.C. Mustazza" 4 => "R. Foa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Haematologica" "fecha" => "2007" "volumen" => "92" "paginaInicial" => "1289" "paginaFinal" => "1290" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17768133" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:3 [ "identificador" => "xack72411" "titulo" => "Acknowledgment" "texto" => "<p id="par0185" class="elsevierStylePara elsevierViewall">We thank Celine Cavallo for English language editing.</p>" ] ] ] "idiomaDefecto" => "en" "url" => "/0213005X/0000003200000001/v1_201401150043/S0213005X13000128/v1_201401150043/en/main.assets" "Apartado" => array:4 [ "identificador" => "8591" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Originales" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/0213005X/0000003200000001/v1_201401150043/S0213005X13000128/v1_201401150043/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X13000128?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 1 | 0 | 1 |
2024 October | 63 | 10 | 73 |
2024 September | 78 | 21 | 99 |
2024 August | 86 | 19 | 105 |
2024 July | 74 | 16 | 90 |
2024 June | 68 | 27 | 95 |
2024 May | 86 | 9 | 95 |
2024 April | 71 | 22 | 93 |
2024 March | 77 | 21 | 98 |
2024 February | 62 | 9 | 71 |
2024 January | 91 | 9 | 100 |
2023 December | 88 | 14 | 102 |
2023 November | 156 | 29 | 185 |
2023 October | 134 | 36 | 170 |
2023 September | 57 | 18 | 75 |
2023 August | 62 | 9 | 71 |
2023 July | 62 | 35 | 97 |
2023 June | 88 | 4 | 92 |
2023 May | 93 | 7 | 100 |
2023 April | 78 | 6 | 84 |
2023 March | 77 | 1 | 78 |
2023 February | 39 | 10 | 49 |
2023 January | 65 | 22 | 87 |
2022 December | 85 | 16 | 101 |
2022 November | 99 | 28 | 127 |
2022 October | 59 | 18 | 77 |
2022 September | 78 | 20 | 98 |
2022 August | 83 | 26 | 109 |
2022 July | 38 | 8 | 46 |
2022 June | 49 | 24 | 73 |
2022 May | 43 | 20 | 63 |
2022 April | 58 | 14 | 72 |
2022 March | 97 | 14 | 111 |
2022 February | 83 | 9 | 92 |
2022 January | 56 | 17 | 73 |
2021 December | 37 | 31 | 68 |
2021 November | 41 | 9 | 50 |
2021 October | 48 | 29 | 77 |
2021 September | 53 | 17 | 70 |
2021 August | 39 | 6 | 45 |
2021 July | 34 | 17 | 51 |
2021 June | 26 | 14 | 40 |
2021 May | 32 | 7 | 39 |
2021 April | 67 | 23 | 90 |
2021 March | 38 | 11 | 49 |
2021 February | 47 | 11 | 58 |
2021 January | 27 | 20 | 47 |
2020 December | 27 | 9 | 36 |
2020 November | 20 | 8 | 28 |
2020 October | 18 | 9 | 27 |
2020 September | 40 | 18 | 58 |
2020 August | 23 | 11 | 34 |
2020 July | 26 | 15 | 41 |
2020 June | 12 | 9 | 21 |
2020 May | 40 | 18 | 58 |
2020 April | 39 | 12 | 51 |
2020 March | 30 | 9 | 39 |
2020 February | 21 | 6 | 27 |
2020 January | 18 | 14 | 32 |
2019 December | 39 | 22 | 61 |
2019 November | 25 | 17 | 42 |
2019 October | 15 | 14 | 29 |
2019 September | 18 | 12 | 30 |
2019 August | 20 | 17 | 37 |
2019 July | 25 | 24 | 49 |
2019 June | 45 | 35 | 80 |
2019 May | 141 | 100 | 241 |
2019 April | 55 | 19 | 74 |
2019 March | 17 | 36 | 53 |
2019 February | 23 | 13 | 36 |
2019 January | 15 | 6 | 21 |
2018 December | 9 | 10 | 19 |
2018 November | 19 | 14 | 33 |
2018 October | 25 | 23 | 48 |
2018 September | 40 | 9 | 49 |
2018 August | 15 | 1 | 16 |
2018 July | 11 | 2 | 13 |
2018 June | 10 | 2 | 12 |
2018 May | 3 | 6 | 9 |
2018 April | 24 | 9 | 33 |
2018 March | 4 | 0 | 4 |
2018 February | 2 | 5 | 7 |
2018 January | 11 | 2 | 13 |
2017 December | 16 | 4 | 20 |
2017 November | 7 | 0 | 7 |
2017 October | 15 | 4 | 19 |
2017 September | 10 | 6 | 16 |
2017 August | 25 | 2 | 27 |
2017 July | 21 | 6 | 27 |
2017 June | 28 | 3 | 31 |
2017 May | 30 | 2 | 32 |
2017 April | 38 | 3 | 41 |
2017 March | 46 | 15 | 61 |
2017 February | 17 | 3 | 20 |
2017 January | 17 | 2 | 19 |
2016 December | 26 | 5 | 31 |
2016 November | 23 | 5 | 28 |
2016 October | 65 | 7 | 72 |
2016 September | 43 | 16 | 59 |
2016 August | 39 | 6 | 45 |
2016 July | 24 | 2 | 26 |
2016 June | 39 | 8 | 47 |
2016 May | 24 | 7 | 31 |
2016 April | 15 | 6 | 21 |
2016 March | 28 | 6 | 34 |
2016 February | 27 | 7 | 34 |
2016 January | 23 | 9 | 32 |
2015 December | 28 | 7 | 35 |
2015 November | 36 | 5 | 41 |
2015 October | 35 | 14 | 49 |
2015 September | 35 | 7 | 42 |
2015 August | 18 | 13 | 31 |
2015 July | 15 | 1 | 16 |
2015 June | 19 | 8 | 27 |
2015 May | 21 | 6 | 27 |
2015 April | 28 | 7 | 35 |
2015 March | 26 | 5 | 31 |
2015 February | 33 | 2 | 35 |
2015 January | 14 | 5 | 19 |
2014 December | 26 | 6 | 32 |
2014 November | 9 | 1 | 10 |
2014 October | 21 | 7 | 28 |
2014 September | 8 | 5 | 13 |
2014 August | 14 | 4 | 18 |
2014 July | 12 | 3 | 15 |
2014 June | 14 | 2 | 16 |
2014 May | 11 | 6 | 17 |
2014 April | 13 | 4 | 17 |
2014 March | 51 | 20 | 71 |
2014 February | 56 | 32 | 88 |
2014 January | 47 | 59 | 106 |